Release Date: 31/10/16 11:53 Summary: Quarterly Cashflow Report-BRB.AX Price Sensitive: Yes Download Document 83.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%